Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,538.00
+18.15 (1.19%)
Mar 28, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 434.87 billion as of March 31, 2025. Its market cap has increased by 61.32% in one year.
Market Cap
434.87B
Enterprise Value
434.47B
Revenue
139.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,538.00
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 434.87B, an increase of 37,737.36%. That is a compound annual growth rate of 28.30%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,162.13B |
| Divi's Laboratories | 1,533.20B |
| Cipla | 1,164.75B |
| Mankind Pharma | 1,000.40B |
| Apollo Hospitals Enterprise | 951.31B |
| Zydus Lifesciences | 891.93B |
| Aurobindo Pharma | 674.02B |
| Alkem Laboratories | 583.68B |